{
    "Case ID": "005752",
    "Crime_Name": [
        "Patent Infringement and Invalidity Dispute"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent Infringement and Invalidity"
    ],
    "Legal_Issue": [
        "Whether Genpharm's allegations of invalidity and non-infringement are justified"
    ],
    "Governing_Law": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Procedural_Stage": [
        "Judicial Review"
    ],
    "Evidence_Assessment": [
        "Analysis of prior art, product formulation, inventive step, expert opinions"
    ],
    "Decision_Outcome": [
        "Genpharm's allegations found unjustified"
    ],
    "Burden_of_Proof": [
        "On Genpharm to substantiate invalidity or non-infringement"
    ],
    "Credibility_Factor": [
        "Court assessed credibility of evidence from both parties"
    ],
    "Legal_Rule": [
        "Generic producer must provide detailed statement on legal and factual basis for invalidity or non-infringement claims"
    ],
    "Standard_of_Review": [
        "Reasonableness or correctness in regulatory context"
    ],
    "Procedural_Issue": [
        "Expedited hearing under the Regulations"
    ],
    "Grounds_for_Claim": [
        "Prior art, formulation differences"
    ],
    "Outcome_on_Merits": [
        "AstraZeneca succeeded on merits"
    ],
    "Decision_Maker": [
        "Court"
    ],
    "Judicial_Review_Outcome": [
        "Application granted"
    ],
    "Review_Standard": [
        "Substantive review of allegations under regulatory framework"
    ],
    "Procedural_Fairness_Assessment": [
        "Fair opportunity to present evidence and arguments"
    ],
    "Key_Evidence_Considered": [
        "Patents '693, '377, '668, '762', expert testimony, prior art, product data"
    ],
    "Legal_Framework": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Applicant_Challenge": [
        "AstraZeneca challenged Genpharm's allegations"
    ],
    "Court_Result": [
        "Order prohibiting NOC issuance to Genpharm until patent expiry"
    ],
    "Legal_Rule_Source": [
        "Regulations"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities"
    ],
    "Defendant_Response": [
        "Genpharm alleged invalidity and non-infringement based on prior art and formulation"
    ],
    "Evidence_Type": [
        "Documentary evidence, expert opinion, technical data"
    ],
    "Remedy_Requested": [
        "Order to prohibit Minister from issuing NOC"
    ],
    "Outcome": [
        "Remedy granted"
    ],
    "Decision_Authority": [
        "Federal Court or relevant regulatory court"
    ],
    "Remedy_Sought": [
        "Interim injunction preventing NOC approval"
    ],
    "Resolution_Mechanism": [
        "Judicial review with expedited hearing"
    ],
    "Legal_Provision": [
        "Sections under Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Authority": [
        "Minister of Health (regulatory authority)"
    ],
    "Claimant_Status": [
        "First person (innovator) - AstraZeneca"
    ],
    "Legal_Provision_Cited": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Lack of sufficient substantiation by Genpharm"
    ],
    "Applicable_Process": [
        "Notice of Compliance (NOC) proceeding"
    ],
    "Outcome_of_Review": [
        "In favor of AstraZeneca"
    ],
    "Pending_Relief_or_Application": [
        "Prohibition of NOC pending patent expiry"
    ],
    "Jurisdiction": [
        "Canada"
    ],
    "Governing_Rule": [
        "Patented Medicines (Notice of Compliance) Regulations"
    ]
}